Literature DB >> 9691465

Ceramides perturb the structure of phosphatidylcholine bilayers and modulate the activity of phospholipase A2.

H W Huang1, E M Goldberg, R Zidovetzki.   

Abstract

The effects of a series of ceramide analogs with acyl chain lengths of 2, 6, 8 and 16 on the structure of diapalmitoylphosphatidylcholine (DPPC) bilayers and cobra venom phospholipase A2 (PL-A2) activity were studied using 2H-NMR and specific enzymatic assays. C2-ceramide did not induce a significant effect on the structure of DPPC bilayers and did not alter PL-A2 activity. C6- and C8-ceramides increased the ordering of the DPPC acyl chains, correlating with the inhibition of PL-A2 activity which was probably due to the increased lateral surface pressure. The long-chain C16-ceramide induced lateral phase separation of the bilayers into gel and liquid crystalline domains and activated PL-A2, as does natural ceramide (Huang et al. 1996). Taken together, the results strongly suggest a correlation between membrane defects induced by ceramide analogs and their effects on phospholipase A2 activity. Furthermore, the effects of short-chain ceramides on PL-A2 are different from those of natural ceramide, indicating that the cell-permeable short-chain ceramide analogs, widely used to study the shpingomyelin-dependent cellular signal transduction pathway, may not completely mimic the natural product.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691465     DOI: 10.1007/s002490050143

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  14 in total

1.  The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis.

Authors:  L J Siskind; M Colombini
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

Review 2.  Ceramide-rich platforms in transmembrane signaling.

Authors:  Branka Stancevic; Richard Kolesnick
Journal:  FEBS Lett       Date:  2010-02-20       Impact factor: 4.124

3.  Role of sphingomyelin and ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2.

Authors:  Dev K Singh; Laurence R Gesquiere; Papasani V Subbaiah
Journal:  Arch Biochem Biophys       Date:  2006-11-21       Impact factor: 4.013

4.  Ceramide-C16 Is a Versatile Modulator of Phosphatidylethanolamine Polymorphism.

Authors:  Mahmoudreza Doroudgar; Michel Lafleur
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

5.  Enhanced Ordering in Monolayers Containing Glycosphingolipids: Impact of Carbohydrate Structure.

Authors:  Erik B Watkins; Shelli L Frey; Eva Y Chi; Kathleen D Cao; Tadeusz Pacuszka; Jaroslaw Majewski; Ka Yee C Lee
Journal:  Biophys J       Date:  2018-03-13       Impact factor: 4.033

6.  Effects of a short-chain ceramide on bilayer domain formation, thickness, and chain mobililty: DMPC and asymmetric ceramide mixtures.

Authors:  Dolores C Carrer; Shirley Schreier; Martín Patrito; Bruno Maggio
Journal:  Biophys J       Date:  2006-01-20       Impact factor: 4.033

7.  Regulation of the activity and fatty acid specificity of lecithin-cholesterol acyltransferase by sphingomyelin and its metabolites, ceramide and ceramide phosphate.

Authors:  Papasani V Subbaiah; Peter Horvath; Srinivasa B Achar
Journal:  Biochemistry       Date:  2006-04-18       Impact factor: 3.162

8.  Ceramides modulate protein kinase C activity and perturb the structure of Phosphatidylcholine/Phosphatidylserine bilayers.

Authors:  H W Huang; E M Goldberg; R Zidovetzki
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

9.  Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids.

Authors:  Fiorella Ciaffoni; Massimo Tatti; Rosa Salvioli; Anna Maria Vaccaro
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

10.  Ceramide acyl chain length markedly influences miscibility with palmitoyl sphingomyelin in bilayer membranes.

Authors:  Bodil Westerlund; Pia-Maria Grandell; Y Jenny E Isaksson; J Peter Slotte
Journal:  Eur Biophys J       Date:  2009-11-12       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.